KPPK Studien

SOLO and AHEAD Study as Co-Investigator and Investigator (Phase  IV)

 

EOS and Helios Study as Co-Investigator (Phase III)

 

ATHENA Study as Co-Investigator (Phase III)

 

CLIMB Study as Investigator (Phase  III)

 

Novartis CQMF149B2201 COPD (Phase II)                     

 

Boehringer Ingelheim, 1205.14 COPD, Eudract No. 2007-001946-42

 

ALK Abello, SHX 0803 GF 18 Allergie, Eudract Nr. 2007-006009-26

 

OM Pharma BV 2007/02, Eudract Nr. 2007-004702-27

 

ALK Abello, SHX 0901AF-H-01, ALK-Flex SXQ, Allergie

 

Boehringer Ingelheim, 205.416 Asthma, Eudract No. 2008-001413-14

 

Boehringer Ingelheim, 1222.12 COPD, Eudract No. 2008-003705-67

 

Chiesi, CCD-0804-PR-0034, Asthma, Eudract No. 2008-004671-22

 

OM Pharma BV 2007/06, COPD, Eurdract No. 2007-005637-11

 

Böhringer Ingelheim BI 1237.18 COPD, Eudract No. 2009-014880-38

 

Bayer Q3939.12965 Bronchiektasen, Eudract No. 2009-009869-34

 

Glaxo HZA 106837, Asthma, Eudract No. 2009-011461-84

 

Böhringer Ingelheim BI 1222.38 COPD, Eudract No. 2009-014416-35

 

Böhringer Ingelheim BI 205.419, Asthma, Eudract No. 2009-018005-43

 

Böhringer Ingelheim BI 205.424,

 

Asthma Kinder Eudract No. 2009-017745-55

 

Böhringer Ingelheim BI 1268.16, Asthma, Eudract No. 2009-014551-80

 

Glaxo GSK  DB 2113374,COPD, Eudract No. 2010-021802-39

 

Böhringer Ingelheim BI 205.444, Asthma, Eudract No. 2010-021093-11

 

Böhringer Ingelheim BI 205.452, COPD, Eudract No. 2009-015713-51

 

Böhringer Ingelheim BI 205.445,

 

Asthma Kinder 6-11 J. Eudract No. 2011-001758-26

 

Glaxo Austri Studie SAS115359 Asthma, Eudract No. 2011-001644-29

 

Böhringer Ingelheim BI 205.446,

 

Asthma Kinder 6-11 J. Eudract No. 2011-001777-43

 

Böhringer Ingelheim BI 205.456,

 

Asthma Kinder groß, Eudract No. 2010-021778-13

 

Böhringer Ingelheim BI 205.425,

 

Asthma Kinder klein, Eudract No. 2010-022458-18

 

Glaxo GSK AC4115408, COPD, Eudract No. 2011-001645-33

 

Cephalon, C38072/3083, Asthma, Eudract No. 2010-024006-35

 

Daxas Nycomed, RO-2455-404-RD, COPD, Eudract No. 2010-019685-87

 

Novartis, CQVA149ADE01, COPD, Eudract No. 2011-004870-26

 

Böhringer Ingelheim BI 1237.5, COPD, Eudract No. 2009-010668-40

 

Böhringer Ingelheim BI 1237.15, COPD, Eudract No. 2011-004253-11

 

Glaxo GSK HZA106853,

 

Asthma Kinder 5-11 J., Eudract No. 2011-003337-34

 

Glaxo, AC4116135, COPD, Eudract No. 2012-001870-27

 

Glaxo, HZA 116863, Asthma, Eudract No. 2012-02797-32

 

MSD Merck, MK 1029, Asthma, Eutract No. 2012-000643-27

 

Bayer, Q3939/1562, Bronchiektasen, Eudract No. 2011-004208-39

 

Novartis, CQVA 149A2318, COPD, Eudract No. 2012-004966-16

 

AMGEN, 20120141, Asthma, Eudract No. 2012-003351-11

 

AB Sience, AB07015, Schweres Asthma, Eudract No. 2010-020803-63

 

Genuair Protokoll No. M34273-32 COPD

 

Glaxo GSK SAS115359,203061, Asthma

 

ICH-GCP Training: Refreshing GCP-Training, 23.03.2012 Koblenz